LeMaitre Vascular Inc
$ 81.45
0.78%
07 Aug - close price
- Market Cap 1,862,701,000 USD
- Current Price $ 81.45
- High / Low $ 81.83 / 79.40
- Stock P/E 28.48
- Book Value 17.80
- EPS 2.86
- Next Earning Report -
- Dividend Per Share $0.90
- Dividend Yield 1.11 %
- Next Dividend Date -
- ROA 0.07 %
- ROE 0.17 %
- 52 Week High 117.72
- 52 Week Low 78.65
About
LeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide. The company is headquartered in Burlington, Massachusetts.
Analyst Target Price
$114.38
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-04 | 2026-05-05 | 2026-02-25 | 2025-11-06 | 2025-08-05 | 2025-05-01 | 2025-02-27 | 2024-10-31 | 2024-08-01 | 2024-05-02 | 2024-02-27 | 2023-11-01 |
| Reported EPS | 0.74 | 0.68 | 0.68 | 0.75 | 0.6 | 0.48 | 0.49 | 0.49 | 0.52 | 0.44 | 0.38 | 0.33 |
| Estimated EPS | 0.81 | 0.66 | 0.66 | 0.56 | 0.57 | 0.5 | 0.49 | 0.43 | 0.47 | 0.39 | 0.36 | 0.3 |
| Surprise | -0.07 | 0.02 | 0.02 | 0.19 | 0.03 | -0.02 | 0 | 0.06 | 0.05 | 0.05 | 0.02 | 0.03 |
| Surprise Percentage | -8.642% | 3.0303% | 3.0303% | 33.9286% | 5.2632% | -4% | 0% | 13.9535% | 10.6383% | 12.8205% | 5.5556% | 10% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | May 2025 | Jan 1970 | Mar 2025 | Dec 2024 | Aug 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-09-03 | 2026-06-04 | 2026-03-26 | 2025-12-04 | 2025-09-04 | 2025-05-29 | None | 2025-03-27 | 2024-12-05 | 2024-08-29 |
| Amount | $0.25 | $0.25 | $0.25 | $0.2 | $0.2 | $0.2 | $0.2 | $0.2 | $0.16 | $0.16 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: LMAT
2026-08-10 08:40:37
Quantinno Capital Management LP significantly increased its stake in LeMaitre Vascular, Inc. by 357.4%, acquiring 18,204 additional shares. This brings their total holding to 23,298 shares, valued at approximately $2.54 million. The news comes as LeMaitre Vascular faces mixed analyst sentiment due to missing Q2 revenue and earnings estimates, although it did report a 9.6% year-over-year revenue growth.
2026-08-08 08:11:19
LeMaitre Vascular, Inc. recently missed its statutory earnings estimates, causing its shares to drop by 21%. Despite the earnings miss, revenue remained in line with predictions, and analysts have largely maintained their price targets, though they slightly downgraded next year's EPS forecasts. The company is still expected to grow faster than the overall industry, with long-term prospects remaining positive according to analysts.
2026-08-07 17:10:42
LeMaitre Vascular (NASDAQ: LMAT) shares fell 21% after missing statutory earnings estimates, though revenues were in line with predictions. Analysts have since slightly downgraded their earnings per share forecasts for 2026, yet the consensus price target remained unchanged at US$114, implying that the valuation is not expected to be significantly impacted. The company is still projected to grow revenues faster than the broader industry.
2026-08-07 17:10:42
LeMaitre Vascular (LMAT) reported strong Q2 2026 results with increased sales and net income, affirming its quarterly dividend. While analysts view the stock as 31.4% undervalued with a fair value of $118.75 due to a strong product pipeline and pricing power, Simply Wall St's DCF model suggests it is overvalued at $81.45 compared to an estimated future cash flow value of $69.27. Investors are encouraged to review these differing valuations and consider the company's risks and opportunities.
2026-08-07 04:15:00
LeMaitre Vascular, Inc. announced its participation in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference, where management will hold investor meetings on August 11, 2026. The company specializes in providing devices, implants, and services for treating peripheral vascular disease, catering to vascular surgeons. Additional information about LeMaitre, including its contact details, is available on its website.
2026-08-07 04:11:19
LeMaitre Vascular, Inc. announced its participation in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference, scheduled for Tuesday, August 11, 2026. Management will hold investor meetings at this event. LeMaitre is a medical device company specializing in products for peripheral vascular disease.
